TY - JOUR
T1 - Modes of failure with fractional flow reserve guidewires
T2 - Insights from the manufacturer and user facility device experience database
AU - Khalid, Nauman
AU - Pandey, Yagya
AU - Khalid, Umair
AU - Kamran, Hassan
AU - Wermers, Jason P.
AU - Chhabra, Lovely
AU - Alam, Mahboob
AU - Jneid, Hani
AU - Kayani, Waleed Tallat
N1 - Publisher Copyright:
© 2021 Baishideng Publishing Group Co. All rights reserved.
PY - 2021/7/26
Y1 - 2021/7/26
N2 - Background: Fractional flow reserve (FFR) measurement is commonly used in the cardiac catheterization laboratory to assess the functional significance of coronary arterial plaques. Robust real-world data on complications and modes of failure of FFR guidewires are limited. Aim: To characterize these outcomes by analyzing the post-marketing surveillance data from the United States Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database for commonly used FFR guidewires. Methods: The MAUDE database was queried from January 2010 through April 2020 for 3 FFR guidewires [PressureWire™ X (Abbott), Comet™ (Boston Scientific), and Verrata™ (Philips)] by searching for the following events: "Injury", "malfunction", "death", and "other". This yielded 544 reports. After excluding incomplete reports, 486 reports were analyzed. Results: Guidewire tip fracture was the most commonly reported mode of failure, in 174 (35.8%) cases followed by guidewire kinking (n = 152, 31.3%), communication failure (n = 141, 29.0%), and shaft fracture (n = 67, 13.8%). In total, 133 (27.4%) device failures resulted in patient adverse events. The most common adverse event was retained guidewire tip, in 71 (53.4%) cases, followed by freshly deployed stent dislodgment (n = 26, 19.6%) and coronary artery dissection (n = 23, 17.3%). Seven deaths were reported. Conclusion: FFR guidewire failures can occur because of various mechanisms and cause patient adverse events. The MAUDE database serves as an important platform for improved collaboration among clinicians, device manufacturers, and regulators to improve device performance and optimize patient outcomes. Our analysis provides mechanistic insights of FFR guidewire failure and associated adverse events but cannot verify causality or provide a comparison among different guidewires.
AB - Background: Fractional flow reserve (FFR) measurement is commonly used in the cardiac catheterization laboratory to assess the functional significance of coronary arterial plaques. Robust real-world data on complications and modes of failure of FFR guidewires are limited. Aim: To characterize these outcomes by analyzing the post-marketing surveillance data from the United States Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database for commonly used FFR guidewires. Methods: The MAUDE database was queried from January 2010 through April 2020 for 3 FFR guidewires [PressureWire™ X (Abbott), Comet™ (Boston Scientific), and Verrata™ (Philips)] by searching for the following events: "Injury", "malfunction", "death", and "other". This yielded 544 reports. After excluding incomplete reports, 486 reports were analyzed. Results: Guidewire tip fracture was the most commonly reported mode of failure, in 174 (35.8%) cases followed by guidewire kinking (n = 152, 31.3%), communication failure (n = 141, 29.0%), and shaft fracture (n = 67, 13.8%). In total, 133 (27.4%) device failures resulted in patient adverse events. The most common adverse event was retained guidewire tip, in 71 (53.4%) cases, followed by freshly deployed stent dislodgment (n = 26, 19.6%) and coronary artery dissection (n = 23, 17.3%). Seven deaths were reported. Conclusion: FFR guidewire failures can occur because of various mechanisms and cause patient adverse events. The MAUDE database serves as an important platform for improved collaboration among clinicians, device manufacturers, and regulators to improve device performance and optimize patient outcomes. Our analysis provides mechanistic insights of FFR guidewire failure and associated adverse events but cannot verify causality or provide a comparison among different guidewires.
KW - Adverse events
KW - Coronary guidewire
KW - Food and Drug Administration
KW - Fractional flow reserve
KW - Manufacturer and user facility device experience
KW - Modes of failure
UR - http://www.scopus.com/inward/record.url?scp=85111551042&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111551042&partnerID=8YFLogxK
U2 - 10.4330/wjc.v13.i7.223
DO - 10.4330/wjc.v13.i7.223
M3 - Article
AN - SCOPUS:85111551042
SN - 1949-8462
VL - 13
SP - 223
EP - 229
JO - World Journal of Cardiology
JF - World Journal of Cardiology
IS - 7
ER -